Study of safety and efficacy of transplantation of platelet extracted mitochondria in heart ischemic stroke, Clinical trial phase 1 and 2
Phase 1
Recruiting
- Conditions
- Heart Ischemia.Acute ischemic heart disease, unspecifiedI24.9
- Registration Number
- IRCT20210920052524N1
- Lead Sponsor
- Rasht University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 34
Inclusion Criteria
Participants, their close relatives or lawyers are able to sign a consent form;
Patients with recent myocardial ischemia within 24 hours
Candidate for interventional treatment.
Ejection fraction less than or equal to 41% (EF = 41%).
The age range is between 45-70 years
Both Genders
Exclusion Criteria
Patients with mitochondrial disorders.
Patients with diabetes
Patients with renal failure.
Pregnant women
Patients with cancer are not included in the study.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method